Roadzen Inc. current report, 22 April 2024

Открыть документ

Roadzen Inc. Form 8-K Summary

Business Context and Reporting Period

Roadzen Inc. filed this Current Report on April 26, 2024, reporting an event occurring on April 22, 2024. The filing concerns warrant issuances connected to a March 28, 2024 Securities Purchase Agreement for up to $2.0 million of senior secured notes.

Transaction and Key Financial Terms

  • The Company agreed to issue and sell up to $2.0 million of principal amount of senior secured notes to Supurna VedBrat and Krishnan-Shah Family Partners, LP.
  • Ms. VedBrat is a Company director. Ajay Shah, another director, and his wife are trustees of the general partner of Krishnan-Shah Family Partners, LP.
  • On April 22, 2024, Roadzen issued Krishnan-Shah Family Partners, LP warrants to purchase 50,000 ordinary shares.
  • The Company expected to issue warrants to Ms. VedBrat for an unspecified number of ordinary shares.
  • The filing does not provide the amount of notes funded, interest rate, maturity, repayment terms, or current liquidity and debt balances.

Warrant Terms, Outlook, and Risks

  • For each $10,000 of original principal amount of notes purchased, the purchasers are entitled to warrants to purchase 1,000 ordinary shares.
  • Warrants generally become exercisable on March 28, 2025, or earlier under specified circumstances, and expire on March 28, 2031, or earlier upon dissolution, liquidation, or winding up of the Company.
  • The exercise price is 80% of the lowest of specified measures, including the 60-trading-day VWAP after the first loan funding, the opening price of certain equity offerings within six months after issuance, and the 60-trading-day VWAP before the vesting date.
  • The warrants include customary anti-dilution protections for certain dividends, distributions, share subdivisions, combinations, or reclassifications.
  • The warrants were sold in unregistered transactions relying on Section 4(a)(2) and Rule 506 of Regulation D.
  • The variable exercise-price formula and anti-dilution provisions may result in future equity dilution; the extent cannot be determined from the filing.
  • The transaction involves related parties, creating governance and potential conflict-of-interest considerations.

Material Changes Versus the Prior Comparable Period

This filing does not present period-over-period operating or financial results. Relative to the Company’s April 4, 2024 Form 8-K, it reports the issuance of 50,000 warrants to Krishnan-Shah Family Partners, LP and provides the warrant terms.

Investor Verification Items

  1. Verify the total principal amount of notes actually funded and the remaining availability under the up-to-$2.0 million commitment.
  2. Confirm whether warrants were issued to Ms. VedBrat and, if so, the number of shares covered.
  3. Review the complete warrant agreement, including exercise-price adjustments and early-exercise provisions.
  4. Assess the potential dilution under the variable exercise-price formula and any future equity offering.
  5. Review the related-party approvals, disclosures, note security interests, interest rate, maturity, and repayment terms.
  6. Confirm the Company’s current cash position, liquidity needs, and other secured or senior obligations, which are not provided in this filing.